A Single-Center, Open-Label, One-Sequence, 2-Period, Within-Subject Study in 2 Cohorts to Investigate the Effect of Multiple Doses of Itraconazole (Cohort 1) and Fluoxetine (Cohort 2) on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Balovaptan (Primary) ; Fluoxetine; Itraconazole
- Indications Psychotic disorders
- Focus Pharmacokinetics
- Sponsors Roche
- 24 Jan 2014 Status changed from active, no longer recruiting to completed; according to ClinicalTrials.gov record.
- 18 Nov 2013 Planned End Date changed from 1 Nov 2013 to 1 Dec 2013as reported by ClinicalTrials.gov.
- 13 Nov 2013 Planned end date changed from 1 Dec 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.